Decades in the making, MCAM enters initial human testing
November 10, 2026
After several years of development, a promising drug designed to prevent relapse to opioid use and opioid overdose is taking a critical step by entering human testing. In October, scientists at The University of Texas at San Antonio Health Science Center launched the first-in-human clinical trial of methocinnamox, or MCAM, a novel long-acting opioid receptor […]
